Tazemetostat hydrobromide, Purity ≥98%

Cat. No.: X24-05-ZQ538

Tazemetostat hydrobromide, Purity ≥98%

Synonym: 1467052-75-0; EPZ-6438 hydrobromide; EPZ6438; EPZ 6438; E-7438 hydrobromide; E 7438; E7438; Histone methyltransferase inhibitor

  • CAS Number: 1467052-75-0
  • Compound CID: 71761627
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Tazemetostat hydrobromide inhibits the enzymes that add methyl groups to histone proteins, altering chromatin structure and gene expression.
Molecular Weight
653.65
Molecular Formula
C34H45BrN4O4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Tazemetostat hydrobromide can be used to inhibit EZH2 in cancer therapies, particularly lymphomas.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.